Jeffrey T. Yorio
Hematology | Oncology
6204 Balcones Dr
Austin, TX 78731
Austin, TX 78731
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Estimated cost of VEGFR TKI associated adverse events in metastatic renal cell carcinoma patients.
Journal: BMC health services research
Published: April 23, 2024
A Phase 2 Study of Sitravatinib in Combination with Nivolumab in Patients with Advanced or Metastatic Urothelial Carcinoma.
Journal: European urology oncology
Published: October 18, 2023
Combined lenvatinib and pembrolizumab as salvage therapy in advanced adrenal cortical carcinoma.
Journal: Journal for immunotherapy of cancer
Published: June 18, 2020
Fulminant Hepatic Failure after Chemosaturation with Percutaneous Hepatic Perfusion and Nivolumab in a Patient with Metastatic Uveal Melanoma.
Journal: Case reports in oncological medicine
Published: April 28, 2020
Treatment decisions in a man with Hodgkin lymphoma and Guillian-Barré syndrome: a case report.
Journal: Journal of medical case reports
Published: September 03, 2014
An interprofessionally developed geriatric oncology curriculum for hematology-oncology fellows.
Journal: Journal of geriatric oncology
Published: July 26, 2014
Case of vemurafenib-induced Sweet's syndrome.
Journal: The Journal of dermatology
Published: September 06, 2013
Rare Though Not Mutually Exclusive: A Report of Three Cases of Concomitant KRAS and BRAF Mutation and a Review of the Literature.
Journal: Journal of Cancer
Published: December 18, 2012
A Primer on the Current State-of-the-Science Neoadjuvant and Adjuvant Therapy for Patients with Locally Advanced Rectal Adenocarcinomas.
Journal: International journal of surgical oncology
Published: February 09, 2012
Socioeconomic disparities in lung cancer treatment and outcomes persist within a single academic medical center.
Journal: Clinical lung cancer
Published: November 22, 2011
Showing 1-12 of 12
Last Updated: 09/26/2026